Cat.#: ACPP-1455
| Despition | PIN1 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Form | Sterile filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1641 | Adenylate cyclase 1 Blocking Peptide (AC1641) | 250 µg | inquiry |
| ACPP-1405 | Human Ciliary Neurotrophic Factor (Active) Protein (AC1405) | 100 µg | inquiry |
| ACPP-1358 | CRMP3 Blocking Peptide (AC1358) | 250 µg | inquiry |
| ACPP-1375 | Human GABARAPL1 Protein (AC1375) | 5 µg | inquiry |
| ACPP-1120 | Human NRG1 Protein (AC1120) | 10 µg | inquiry |
| ACPP-1154 | Recombinant Human FGF19 Protein (6×His Tag) (AC1154) | 50 µg | inquiry |
| ACPP-1029 | Recombinant Human beta Nerve Growth Factor Protein (AC1029) | 50 µg | inquiry |
| ACPP-1339 | MRAP2 Blocking Peptide (AC1339) | 250 µg | inquiry |
| ACPP-1044 | Recombinant Human RAGE Protein (6×His Tag) (AC1044) | 50 µg | inquiry |
| ACPP-1364 | Estrogen Receptor alpha Blocking Peptide (AC1364) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.